FDA Clearance Tracker · P170042-S003
Covera Vascular Covered Stent
Last checked: Nov 20, 2026Latest source record: Oct 31, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 31, 2019
Approved
Time to decision
213 days
Received Apr 1, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170042-S003
- Device name
- Covera Vascular Covered Stent
- Applicant
- C.R. Bard, Inc.
- Applicant location
- Tempe, AZ
- Received
- Apr 1, 2019
- Decided
- Oct 31, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P170042
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the protocols for the post-approval studies (PAS) protocol.
Source documents
Other decisions for C.R. Bard, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.